The SEC-SOR-LYC group had a notably reduced amount of VEGF in the tumor tissue by 38% in contrast to the SEC-Control group and by 15% and 25% when compared to the SEC-SOR and SEC-LYC groups alone (Figure 7B). This evidence concerns the gene VEGFA and neoplasm.